Table 1.
Demographic and Illness-related Characteristics (N = 138)
| Characteristic | N | % | M | SD | Range |
|---|---|---|---|---|---|
| Age | 37.6 | 5.2 | 22 - 48 | ||
| Race/Ethnicity | |||||
| African American | 53 | 38% | |||
| Puerto Rican | 47 | 34% | |||
| White | 38 | 28% | |||
| Education | |||||
| > High School | 47 | 34% | |||
| High School or GED | 40 | 29% | |||
| Some College or Technical School | 40 | 29% | |||
| College Graduate | 11 | 8% | |||
| Income | |||||
| > $10,000 | 72 | 52% | |||
| $10,000 - $19,999 | 37 | 27% | |||
| $20,000 - $34,999 | 15 | 11% | |||
| $35,000 or more | 14 | 10% | |||
| Marital Status | |||||
| Single | 70 | 51% | |||
| Married / Common Law | 24 | 17% | |||
| Separated / Divorced | 35 | 25% | |||
| Widowed | 9 | 7% | |||
| Parental Status | |||||
| Has Children | 118 | 86% | |||
| History of Injecting Drug Use | 42 | 30% | |||
| Disease Stage | |||||
| Asymptomatic | 19 | 14% | |||
| Symptomatic | 49 | 36% | |||
| AIDS | 70 | 51% | |||
| Antiretroviral Treatments | |||||
| Currently taking Protease Inhibitors | 51 | 37% | |||
| No longer taking Protease Inhibitors | 41 | 30% | |||
| Never used Protease Inhibitors | 46 | 33% | |||
| Most recent CD4 cell count (self-reported) | 327.4 | 309.9 | 0 - 1530 | ||
| Time Since HIV Diagnosis (in years) | 7.3 | 4.0 | 0.33 - 17.8 | ||
| Number of HIV-related Symptoms | 10.6 | 6.2 | 0 - 23 |